Global Sample Validity Testing Reagents Industry 2021-2029



Dublin, December 21, 2021 (GLOBE NEWSWIRE) – The report “Sample Validity Testing Reagents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecast, 2021 to 2029 ”has been added to ResearchAndMarkets.com offer.

The global Sample Validity Testing Reagents market is expected to grow at a CAGR of 7%. Emerging technology and innovation in healthcare has developed specimen validity testing through urine samples.

The Sample Validity Test (SVT) is performed on a urine drug test sample to detect substitution, adulteration, or dilution. It provides clinicians with essential information about the accuracy and reliability of drug test results. Drug testing is a well-established and readily available clinical tool for objectively assessing an individual’s illicit drug use behaviors.

Illicit drug use is defined as the use of marijuana, cocaine, heroin, hallucinogens, inhalants, or the non-medical use of prescriptions. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), nearly 8.7% of the US population aged 12 or older uses illicit drugs.

The market is driven by screening for illicit drug use by many people in various regions. Increasing number of drug addict populations and the strict regulatory guidelines enforced by regulatory bodies in developed countries such as United States are the major factors driving the growth of SVT Reagents market. North America alone contributed over 60% of the total market share in 2020.

Youth use of illicit drugs drives the market

Illicit drugs include marijuana, opioids, cocaine, and other drugs. The World Health Organization (WHO) reports that cannabis is the most widely used illicit drug in the world, accounting for half of all drug seizures worldwide. An estimated 147 million people while 2.5% of the world’s population uses marijuana each year. The United States: 5.89%, Greenland: 5.63%, Mongolia: 5.24%, the United Kingdom: 5.22% and New Zealand: 4.91% are the top 5 countries with the main illicit drugs.

These countries are also having substantial growth in healthcare for testing people with heavy drug use. Validity testing of specimens is carried out on a large scale in these countries. As a result, many people end up in rehabilitation centers, strict laws are put in place to control the drug market. The market for sample validity testing tends to grow due to the high use of illicit drugs. The market is expected to grow in the future.

North America dominates the market and Asia-Pacific is emerging

Despite strict drug policies and punitive laws, the United States has high levels of lifelong illegal drug use. A 2018 study found that the United States has some of the highest rates of illicit drug use in the world. Eastern European countries recorded the highest rates of alcohol consumption. The 2019 NSDUH reported that more than 12 million young adults (aged 18 to 25) use marijuana. Results from the 2019 NSDUH indicated that 3.5% of the U.S. population aged 12 and over was misusing prescription pain relievers. In the 2019 NSDUH, there were approximately 97,000 people aged 12 and over in the United States who had used cocaine in the past year. As a significant increase in the market, the market grew dramatically as testing increased alongside drug use. Asia-Pacific was the emerging growth region, followed by North America and Europe.

Impact of COVID-19 on the market

The continued stress and uncertainty of COVID-19 has led to an increased demand for mental health services from psychologists in the United States, but conditions such as anxiety and depression are not the only problems. mental health that people face. Experts say abuse of opioids and stimulants is also on the rise, and psychologists are in a good position to help. In 2020, according to the American Medical Association report in December, more than 40 U.S. states saw increased opioid-related mortality as well as lingering concerns for people with substance use disorders. The pandemic represented major tests in many regions as drug use increased.

Historical and forecast period

This research report presents the analysis of each segment from 2019 to 2029 considering 2020 as the base year for the research. The compound annual growth rate (CAGR) for each respective segment is calculated for the forecast period 2021 to 2029.

Key Quest Answered

  • What are the key market segments in the current scenario and in the future by product categories?

  • What are the key market segments in the current scenario and in the future by region?

  • What is the key impact of COVID-19 on market revenue and market determinants in the Sample Validity Testing Reagents market?

  • What are the primary and secondary macro and micro factors influencing the growth of the market now and over the forecast period?

  • What are the primary and secondary macro and micro factors that deter the growth of the market now and during the forecast period?

  • How to overcome the current challenges of the market and take advantage of the opportunities of each of the market segments?

  • Who are the major players in the Sample Validity Testing Reagents market and what are their major product categories and strategies?

  • What are the key strategies – mergers / acquisitions / R & D / strategic partnerships, etc. that companies are deploying to improve revenue and market growth?

Key topics covered

Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Market Dynamics
Chapter 4 Sample Validity Testing Reagents (SVTR) Market, By Product
Chapter 5 Sample Validity Testing Reagents (SVTR) Market, By Test Type
Chapter 6 Sample Validity Testing Reagents (SVTR) Market, By Application Areas
Chapter 7 North America Sample Validity Testing Reagents Market Analysis
Chapter 8 Europe Sample Validity Testing Reagents Market Analysis
Chapter 9 Asia-Pacific Sample Validity Testing Reagents Market Analysis
Chapter 10 Rest of the World (SVTR) Sample Validity Testing Reagents Market Analysis
Chapter 11 Company Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/xtitnz

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Previous Turkey hit by another illicit alcohol incident as death toll exceeds 50
Next Biden doubles down on deadly drug strategy